Remove Aortic Remove Heart Valves Remove Innovation
article thumbnail

Ismail El-Hamamsy, MD, PhD, Named President of the Heart Valve Society

DAIC

Photo courtesy of Mount Sinai Health System milla1cf Thu, 02/22/2024 - 13:47 February 22, 2024 — Ismail El-Hamamsy , MD, PhD, Director of Aortic Surgery for the Mount Sinai Health System and the Mount Sinai Randall B.

article thumbnail

Direct aortic TAVI via anterior right mini-thoracotomy using 32 mm myval for pure aortic regurgitation

Journal of Cardiothoracic Surgery

Background Aortic regurgitation with dilated annulus presents a technical challenge for conventional transcatheter aortic valve implantation (TAVI) procedures. The patient recovered well post-operatively with good hemodynamic resolution.

Aortic 52
article thumbnail

Heart Valve Disease Forum 2023

Society of Thoracic Surgeons - Allied Health

The program directors have chosen an ambitious theme of "The Taming of the Aortic Valves," inspired by Shakespeare's classic The Taming of the Shrew. Trainees, residents, and practicing physicians will train on surgical techniques via wet labs, and hear the latest on TAVI, innovative SAVR, and endocarditis.

article thumbnail

Artificial intelligence in heart valve disease: diagnosis, innovation and treatment. A state-of-the-art review

The British Journal of Cardiology

In recent years, artificial intelligence (AI) has been used to improve the precision of valvular heart disease diagnosis and treatment. It has the ability to identify and risk stratify patients with valvular heart disease and holds promise in improving the innovation of new treatments through shorter, safer and more effective clinical trials.

article thumbnail

Edwards Lifesciences Expands Structural Heart Portfolio With Acquisitions of JenaValve and Endotronix

DAIC

mtaschetta-millane Mon, 07/29/2024 - 09:02 July 29, 2024 — Edwards Lifesciences announced investments that reflect the company’s deep commitment to advancing patient care through structural heart innovation, addressing large unmet patient needs and supporting sustainable long-term growth. billion.

article thumbnail

Laguna Tech USA Announces Site Record Number of Transcatheter Heart Valves Implanted at Single Center on Same Day in First-in-Human Clinical Trial

DAIC

In all cases, patients achieved complete resolution of aortic disease with no residual stenosis or regurgitation immediately following the procedure, and all patients were discharged within 24-48 hours of the procedure.

article thumbnail

Medtronic Launches the Avalus Ultra Valve Engineered for Ease of Use at Implant and Lifetime Patient Management

DAIC

Getty Images milla1cf Thu, 06/13/2024 - 20:38 June 13, 2024 — Medtronic plc, a global leader in healthcare technology, today announced the launch of its latest innovation in cardiac surgery, the Avalus Ultra valve. A treatment for patients with aortic valve disease is surgical aortic valve replacement (SAVR).